Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Target Discovery | Whitepapers & Reports

Validation of an Impedance-based Cytotoxicity Assay for High Throughput Screening

09 June 2022
High throughput screening requires careful validation of assay performance
Open document in a new tab

Related Resources

The Application of RNAi Therapeutics for Cardiovascular Disease Treatment

Alnylam Pharmaceuticals explores the possibility of treating cardiovascular disease with RNAi therapeutics.
Read More

The Power of Philanthropy in Transforming Pancreatic Cancer Research

The Stephenson Prize for innovation in pancreatic cancer research was launched alongside a $150 million gift to City of Hope.
Read More